Drug Notebook

Media Gallery
Drug Info Tools
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Licensed from
hydrochlorothiazide
Page: < Back 1 2 3 4 5 6 Next >
(hye dro klor o THY a zide)

Dosage and Administration

Administration

Administer orally.

Dosage

Individualize according to requirements and response. Use lowest dosage necessary to produce desired clinical effect.

If added to potent hypotensive agent regimen, initially reduce hypotensive dosage to avoid the possibility of severe hypotension.

Pediatric Patients

Usual Dosage

Oral

Infants <6 months of age: Up to 3 mg/kg daily, in 2 divided doses; up to 37.5 mg daily.

Infants 6 months to 2 years of age: Usually, 1–2 mg/kg daily, in a single or 2 divided doses, up to 37.5 mg daily.

Children 2–12 years of age: 1–2 mg/kg daily, in a single or 2 divided doses, up to 100 mg daily.

Hypertension

Oral

Initially, 1 mg/kg once daily. Increase dosage as necessary up to a maximum of 3 mg/kg (up to 50 mg) once daily.

Adults

Hypertension

BP Monitoring and Treatment Goals

Carefully monitor BP during initial titration or subsequent upward adjustment in dosage.

Avoid large or abrupt reductions in BP.

Adjust dosage at approximately monthly intervals (more aggressively in high-risk patients [stage 2 hypertension, comorbid conditions]) if BP control is inadequate at a given dosage; it may take months to control hypertension adequately while avoiding adverse effects of therapy.

SBP is the principal clinical end point, especially in middle-aged and geriatric patients. Once the goal SBP is attained, the goal DBP usually is achieved.

The goal is to achieve and maintain a lifelong SBP <140 mm Hg and a DBP <90 mm Hg if tolerated.

The goal in hypertensive patients with diabetes mellitus or renal impairment is to achieve and maintain a SBP <130 mm Hg and a DBP <80 mm Hg.

Monotherapy
Oral

Initially, 12.5–25 mg daily.

Gradually increase until the desired therapeutic response is achieved or adverse effects become intolerable, up to 50 mg daily.

If adequate response is not achieved at maximum dosage, add or substitute another hypotensive agent.

Maintenance

Usually, 12.5–50 mg once daily.

Combination Therapy
Oral

Initially, administer each drug separately to adjust dosage.

May use fixed combination if optimum maintenance dosage corresponds to drug ratio in combination preparation.

Administer each drug separately whenever dosage adjustment is necessary.

Alternatively, may initially use certain (low-dose hydrochlorothiazide/other antihypertensive) fixed combinations for potentiation of antihypertensive effect and minimization of potential dose-related adverse effects of each drug.

Edema

Oral

Usually, 25–100 mg daily in 1–3 divided doses.

Many patients also may respond to intermittent therapy (e.g., alternate days, 3–5 days weekly); decreased risk of excessive diuretic response and resulting electrolyte imbalance.

Prescribing Limits

Pediatric Patients

Usual Dosage

Oral

Infants <2 years of age: Maximum 37.5 mg daily.

Children 2–12 years of age: Maximum 100 daily.

Hypertension

Oral

Maximum 3 mg/kg (up to 50 mg) once daily.

Adults

Hypertension

Oral

Maximum before switching/adding alternative drug is 50 mg daily.

Higher dosages had been used in the past (up to 200 mg daily) but no longer are recommended because of the risk of adverse effects (e.g., markedly decreased serum potassium). Instead, switch to or add alternative drug.

Special Populations

Dosage in Hepatic Impairment

No specific dosage recommendations for hepatic impairment; caution because of risk of precipitating hepatic coma.

Dosage in Renal Impairment

No specific dosage recommendations for renal impairment; caution because of risk of precipitating azotemia.

Geriatric Patients

Initiate therapy at the lowest dosage (12.5 mg daily); may adjust dosage in increments of 12.5 mg if needed.

Page: < Back 1 2 3 4 5 6 Next >
Advertisement
Back to Top